RT Conference Proceedings
T1 DETERMINING THE VALUE OF OCREVUS (R) (OCRELIZUMAB) FOR THE TREATMENT OF MULTIPLE SCLEROSIS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)
A1 Alerany, C.
A1 Fernandez, R.
A1 Landete, L.
A1 Rodriguez, A.
A1 Sandoval, S.
A1 Valdivia, M.
A1 Gil, A.
PB Elsevier science inc
SN 1098-3015
YR 2018
FD 2018-10-01
LK https://hdl.handle.net/10668/27568
UL https://hdl.handle.net/10668/27568
LA en
DS RISalud
RD Apr 17, 2025